TomoTherapy Incorporated announced that Swedish Cancer Institute (SCI) has installed the first TomoTherapy® radiation therapy system in the Seattle area at its new, community-based Radiation Treatment Center on the Ballard campus.
“We selected the TomoTherapy system because it’s a promising technology with many advantages—from the complete integration of treatment planning, imaging, and treatment delivery, to its flexibility in treating a wide range of cancers,” said Dan Landis, MD, PhD, the lead physician at the SCI facility on the Swedish/Ballard campus. “In a large system like ours, we want to be able to offer our patients the very best care in every situation, and TomoTherapy technology gives us the ability to do so.”
The ring-like design of the system enables helical delivery of radiation from all angles around a patient, and features beam-shaping technology specifically designed for delivering intensity-modulated radiation therapy (IMRT). These features provide clinicians with greater control of how they can conform radiation delivery to complex tumors while minimizing damage to surrounding healthy tissues.
Swedish Cancer Institute also will be using the TomoTherapy system’s TomoDirect™ capabilities at the Ballard campus. The TomoDirect radiation delivery mode is a non-rotational delivery option that enables clinicians to quickly plan and deliver advanced radiation treatments by applying multiple, carefully directed radiation beams to the target area.
“Swedish Cancer Institute is one of the premier cancer institutions in the Pacific Northwest and we are pleased to be partnering with them to bring the advantages of the TomoTherapy system to the Seattle area,” said Fred Robertson, MD, TomoTherapy’s CEO.